VANTA BIOSCIENCE LIMITEDVANTA BIOSCIENCE LIMITEDVANTA BIOSCIENCE LIMITED

VANTA BIOSCIENCE LIMITED

No trades
See on Supercharts
Market capitalization
‪419.75 M‬INR
−7.06INR
‪−64.81 M‬INR
‪58.29 M‬INR
‪1.72 M‬
Beta (1Y)
0.67

About VANTA BIOSCIENCE LIMITED

CEO
Dopesh Raja Mulakala
Headquarters
Hyderabad
Employees (FY)
47
Founded
2016
ISIN
INE695X01011
FIGI
BBG00HPJMGX7
Vanta Bioscience Ltd. engages in the full service preclinical contract research organization. Its services include Discovery Toxicology, Agro-Chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation and Batch Release Test. The company was founded on April 29, 2016 and is headquartered in Hyderabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VANTABIO is 63.19 INR — it has decreased by 4.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange VANTA BIOSCIENCE LIMITED stocks are traded under the ticker VANTABIO.
VANTABIO stock is 5.24% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is VANTA BIOSCIENCE LIMITED there?
Yes, you can track VANTA BIOSCIENCE LIMITED financials in yearly and quarterly reports right on TradingView.
VANTABIO stock has fallen by 1.27% compared to the previous week, the month change is a 4.98% fall, over the last year VANTA BIOSCIENCE LIMITED has showed a 14.79% increase.
VANTABIO net income for the last quarter is ‪−5.36 M‬ INR, while the quarter before that showed ‪−39.20 M‬ INR of net income which accounts for 86.32% change. Track more VANTA BIOSCIENCE LIMITED financial stats to get the full picture.
No, VANTABIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VANTABIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VANTA BIOSCIENCE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
VANTABIO reached its all-time high on Mar 8, 2021 with the price of 195.50 INR, and its all-time low was 37.00 INR and was reached on Nov 8, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 47.00 employees. See our rating of the largest employees — is VANTA BIOSCIENCE LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VANTA BIOSCIENCE LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VANTA BIOSCIENCE LIMITED stock shows the sell signal. See more of VANTA BIOSCIENCE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VANTA BIOSCIENCE LIMITED EBITDA is ‪2.18 M‬ INR, and current EBITDA margin is −41.07%. See more stats in VANTA BIOSCIENCE LIMITED financial statements.